• Publications
  • Influence
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway
Pro-inflammatory cytokines have been consistently reported to be elevated in schizophrenia patients. However, it is not known whether cytokines influence the presentation of psychotic symptoms. ToExpand
  • 77
  • 7
Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome.
Second-generation antipsychotics (SGAs) are commonly used to treat schizophrenia. However, SGAs cause metabolic disturbances that can manifest as metabolic syndrome (MetS) in a subset of patients.Expand
  • 39
  • 1
Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.
Alcaftadine (Lastacaft®; Allergen, Inc.) is a broad-spectrum antihistamine displaying a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors. It also exhibitsExpand
  • 18
  • 1
Low-Level Primary Blast Induces Neuroinflammation and Neurodegeneration in Rats.
OBJECTIVE Mild blast traumatic brain injury is commonly prevalent in modern combat casualty care and has been associated with the development of neurodegenerative conditions. However, whether primaryExpand
  • 4
Protective Function of Endothelial Glycocalyx (EG) during Hemorrhagic Shock (HS) in Skeletal Muscle: Integration of Systemic and Local Parameters In Vivo
Successful resuscitation after HS requires tissue stabilization and restoration of microcirculatory function. EG shedding may be associated with endothelial and secondary injury, such as edema, infl...
  • 2
Fermented Milks from Small Ruminant: Effect on Metabolism and Immune Status of Mice Fed Mild Caloric Restricted Diet
Fil: Fabersani Marrades, Mario Emanuel. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Tucuman. Centro de Referencia para Lactobacilos (i); Argentina
Metabolomic pro fi ling of schizophrenia patients at risk for metabolic syndrome
Second-generation antipsychotics (SGAs) are commonly used to treat schizophrenia. However, SGAs cause metabolic disturbances that can manifest as metabolic syndrome (MetS) in a subset of patients.Expand